RxDoctor Payments Data

Karen Fuller, NP

Family · Marietta, GANPI 1831731306

Payments from drug & device makers

$1,425in general payments, 2019–2025

Across 77 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$315
  • Lilly USA, LLC$205
  • Ironshore Pharmaceuticals Inc.$123
  • Dynavax Technologies Corporation$79
  • Collegium Pharmaceutical, Inc.$78
  • Exact Sciences$72
  • plus $554 from 16 others

What the payments were for

  • Food & beverage$1,40599%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,425 in reported general payments places this provider in the 70th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$28,693
Medicare patients
151
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin14$17,633
OzempicSemaglutide12$12,261
FarxigaDapagliflozin Propanediol11$10,772
Albuterol Sulfate HfaAlbuterol Sulfate24$704
Gabapentin26$502
Levothyroxine Sodium36$473
Metoprolol Succinate26$467
Amlodipine Besylate62$466
Pantoprazole Sodium38$412
Ezetimibe13$396
Atorvastatin Calcium48$393
Losartan Potassium35$372
Pravastatin Sodium15$348
Sertraline Hcl28$263
Lisinopril48$258

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$18$17,63314 claims
Novo NordiskOzempic$315$12,26112 claims
AstraZenecaFarxiga$41$10,77211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,258 family providers in Georgia.

Other family in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →